.Pharmacolibrary.Drugs.ATC.G.G01AA10_1

Information

name:Clindamycin_1
ATC code:G01AA10_1
route:intravenous
n-compartments2

Clindamycin is a broad-spectrum lincosamide antibiotic, effective against Gram-positive cocci and anaerobic bacteria. Approved and used in treatment of infections such as MRSA, dental infections, and pelvic inflammatory disease.

Pharmacokinetics

Pharmacokinetics after intravenous administration in healthy adults (single 600 mg IV dose).

References

  1. Sullins, AK, & Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatric drugs 15(2) 93–117. DOI:10.1007/s40272-013-0017-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23529866

  2. Bouazza, N, et al., & Tréluyer, JM (2012). Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis. British journal of clinical pharmacology 74(6) 971–977. DOI:10.1111/j.1365-2125.2012.04292.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/22486719

  3. Smith, MJ, et al., & Watt, K (2017). Pharmacokinetics of Clindamycin in Obese and Nonobese Children. Antimicrobial agents and chemotherapy 61(4) –. DOI:10.1128/AAC.02014-16 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28137820

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos